Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-31 @ 2:07 AM
Study NCT ID:
NCT04225533
Status:
COMPLETED
Last Update Posted:
2023-01-30
First Post:
2020-01-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SP16 Inflammatory Response Inhibition Trial
Sponsor:
Serpin Pharma, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2020-01-08
First Submit QC Date:
None
Study First Post Date:
2020-01-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-08
Results First Submit QC Date:
None
Results First Post Date:
2023-01-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2023-01-30
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-01-04
Last Update Post Date:
2023-01-30
Last Update Post Date Type:
ACTUAL